STRAP Strategic Partners A/S
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.…
Industry Peers
BiotechnologyKey Statistics
About Strategic Partners (CPH: STRAP)
›
Strategic Partners (CPH: STRAP) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 1 employees.
The shares were at 555.00 DKK on 19 November 2026, down 32.8% over 52 weeks. Its 52-week range is 515.00 DKK to 946.00 DKK: the price is 41.3% below the high and 7.8% above the low.
At a market capitalisation of 30.03M DKK, it trades at 17.9 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a discount of 47% for STRAP.
Strategic Partners reports return on equity of -4.7% and revenue down 4.8% year over year.
It holds more cash than debt, a net cash position of 16.53M DKK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.